Jen Johnson: Hello hello! So, how is it going at Melbourne Sexual Health Centre? How did the service model evolve during 2020?
Dr Jason Ong: So Melbourne Sexual Health Centre never actually closed, as we always had essential services to deliver. So we stayed open, and were able to provide services, but there were some key differences during the year. The biggest one was actually staffing, many of our clinical staff were seconded to hospitals to help out with the COVID-19 emergency.
Another major change was to do with the HIV clinic, we basically shifted to a telehealth model for all patients except for a small minority.
Many of you would be aware that Melbourne Sexual Health Centre is a very busy service. Over the years we have had to continuously adapt to our service model to meet the high demand for services, which often exceeded our clinical capacity. So we already had processes in place for times when we needed to triage patients out. When the COVID pandemic hit this year, we moved to prioritise people with symptoms and vulnerable people for in-person appointments, and saw those people with no symptoms via a quick telehealth consult followed by self-sampling at our clinic, and also often encouraging them to go and see a GP if possible. Another obvious change was the way we do swabs. In order to better implement physical distancing we moved to a model where patients self-collected their samples (including oropharyngeal swabs), which worked really well.
Lots of health services have reported a reduction in client numbers during 2020, was that the case for MSHC?
Actually we’re just about to publish some of these numbers. We definitely had fewer people after March this year than we did before. During the seven-week period before the March lockdown, we had 7818 consultations. This dropped right down during the first lockdown to 4652 over a seven-week period (which includes in-person and telehealth). It then picked up again in May/June to 5347. So we definitely saw client numbers reduce. It was the number of asymptomatic presentations that dropped the most. Numbers of clients presenting with more severe symptoms, like pelvic inflammatory disease or infectious syphilis, remained about the same.
We have just launched a new website staySTIfree which helps people to identify symptoms and figure out how urgently they need to see a doctor. It also has translated STI information available in eight languages.
What new and different models of testing do you think will be important post-2020?
It has been a challenging year, but it has definitely opened up new avenues. We have been talking for a while about expanding our e-STI testing models, and this year has brought the opportunity to introduce them. E-STI testing is definitely the future of STI testing, where asymptomatic people can organise testing online. It has the potential to increase access to testing for people in remote and regional areas. It is also likely to reduce barriers to testing for the many young people who are more comfortable interfacing with a website than a nurse or doctor. I have a PhD student starting next year to gather evidence to inform future HIV/STI testing models – this will help us to evolve our services to meet the needs of our population, particularly those who are more vulnerable.
And then of course there’s HIV self-testing. We recently ran the PUSH study to try and work out the market for HIV self-testing (HIVST), compared to other types of HIV testing. The PUSH study surveyed over 1600 gay, bisexual men in Australia, and found that a significant minority of men prefer HIVST above other types of testing. Also, those who prefer self-testing are more likely to be infrequent testers, as in they get tested every 2 years or less. The PUSH study also invited men to test using two HIVST kits (oral-based and blood-based), and we found that future HIVST use was particularly attractive to overseas born men (a key subpopulation to reach). So there is lots more work we can do to increase access to HIV self-testing for those who prefer it.
So Melbourne is opening up. Can you give me an idea of what’s happening at MSHC?
In a way, right now, it feels like the calm before the storm. We are in preparation mode, as we are anticipating a significant increase in people coming back into our service, and with that an increase in STI diagnoses and HIV diagnoses. We have more staff back from secondment, and we have got more backup strategies, such as home-sampling if we need to turn people away again.
I hope that we don’t become overloaded again. MSHC was breaking at the seams just before COVID hit due to longstanding systemic funding issues, but we have taken advantage of this quieter time to rethink our service model and prepare for the future. We have been working on a project building up a GP hub-and-spoke model for sexual health services. In the pilot phase we have worked with three Melbourne GP services to support them to provide more specialised sexual health services. These can also operate as overflow services, and they can see asymptomatic people for testing, provide PEP and PrEP, and of course they can deal with more complex sexual health issues. These services also offer an alternative to MSHC (in Carlton) for people who live closer these spoke sites, which are in the north, west and east of Melbourne.
Anything else you’d like to add?
Next week is the Australasian Joint HIV/STI conference and I’m really looking forward to it. It’s encouraging that so many people in our sector want to get together (nearly 800 registrations so far). It is going to be so great to hear about the research everyone has been doing, and to see that sexual health hasn’t dropped off the radar. Lots of people have been very busy!
1 December - World AIDS Day 2020: Now More Than Ever
The national World AIDS Day theme for Australia in 2020 is: Now More Than Ever. World AIDS Day aims to encourage Australians to educate themselves and others about HIV; to take action to reduce the transmission of HIV by promoting prevention strategies; and to ensure that people living with HIV can participate fully in the life of the community, free from stigma and discrimination.
Get the word out by downloading, printing and displaying the WAD Poster or the WAD Banner .
As a community and as individuals, there is a lot we can do in relation to HIV. Working in partnership with people with HIV, we can encourage others to understand how HIV is transmitted. We can support people to access testing, treatment and care, as we know that commencing treatment at the early stages of HIV results in better health outcomes and reduces the likelihood of onward transmission.
UNAIDS’ theme for World AIDS Day 2020 is Global Solidarity, Shared Responsibility. UNAIDS is leading the global effort to end AIDS as a public health threat by 2030 as part of the Sustainable Development Goals. The focus of UNAIDS is on stopping new HIV infections, ensuring that everyone living with HIV has access to HIV treatment, protecting and promoting human rights and producing data for decision-making.
You can show your support for people with HIV on World AIDS Day by wearing a red ribbon: the international symbol of HIV awareness and support.
See ‘events’ below for a selection of Victorian events, and watch this space for more.
Reviewed and updated HIV, hepatitis B and hepatitis C testing policies
The Australian HIV and hepatitis Testing Policies support health professionals ordering HIV, hepatitis C and hepatitis B tests and receiving, interpreting and delivering results to patients. They set out a framework for providing quality testing and removing real and perceived barriers to testing.
Expert Reference Committees guide the development and updating of each testing policy. The three policies can be accessed at the ASHM Testing Portal, as well as summaries of what has changed in the updated HIV , hepatitis B and hepatitis C policies.
New Report from EC: Using hepatitis C notification data to increase access to hepatitis C treatment and cure in Australia: A formative study
The study aimed to explore the potential of using jurisdictional hepatitis C notification data to improve treatment uptake and accelerate the elimination of hepatitis C in Australia. This aim was achieved by:
• Examining the logistical and practical issues and ethical considerations associated with implementing a system of hepatitis C notification follow-up in Australia that would identify and locate people diagnosed with hepatitis C, inform them about DAAs and direct them to treatment services
• Conducting an environmental scan and analysis of health policy, including legislation, strategies and action plans affecting the purpose, collection, use and disclosure of hepatitis C notification data
• Identifying the scope of future initiatives to guide and enhance the use of hepatitis C notifications data to increase hepatitis C treatment uptake in Australia to support achievement of hepatitis C elimination targets.
Access the EC report here
New ASHM resource: U=U: ASHM guidance for healthcare professionals
U=U: ASHM guidance for healthcare professionals draws on the latest evidence to inform healthcare providers about U=U and provides recommendations for speaking about U=U to all patients, including those newly diagnosed with HIV.
‘Undetectable equals untransmissible’, or U=U, refers to the fact that people who take antiretroviral therapy for HIV daily as prescribed, and who achieve and maintain an undetectable viral load, cannot sexually transmit the virus to an HIV-negative partner.
Key changes in this the edition of the guidance include:
- Removing any ambiguity from the message that patients maintaining a ‘durable viral suppression’ (defined as less than 200 HIV RNA copies per mL of blood) eliminates the risk of sexual transmission of HIV, making Australia one of the first countries in the world to support such strong language in support of U=U
- Strengthening our support for the priority of getting people living with HIV (PLHIV) onto effective anti-retroviral treatment as soon as possible after their diagnosis, to ensure better health outcomes
- Highlighting emerging evidence that healthcare providers talking to HIV-positive patients about U=U has a positive impact on self-reported mental, sexual and overall health and wellbeing.
Download the U=U resource here
New report from AFAO and ACOSS: Learning From One Pandemic To Live With Another
This new report outlines how Australia should learn from previous success tackling HIV, which demanded profound behavioural change, frank and honest health promotion and a strong partnership between community groups and government to contain the virus, in the absence of a cure or vaccine. You can also listen to a short discussion about the report on a recent edition of ABC Program The World Today here .
New CSRH report: Understanding trust in digital health among communities affected by BBVs and STIs in Australia
Despite extensive government investment to expand digital health, minimal research has been conducted on community views of these systems in Australia. In particular, there has been scant attention to the perspectives on digital health of populations affected by blood-borne viruses (BBVs) and sexually transmissible infections (STIs). The Trust in Digital Health study was conducted by the Centre for Social Research in Health in partnership with community organisations representing four of the priority populations in the current national BBV/STI strategies: people with HIV, trans and gender diverse people, sex workers, and gay and bisexual men. Access the CSRH report here .
New AIVL resources: The ‘What you need to know about…’ series.
These new AIVL resources are designed to provide information and highlight some of the key issues that follow on from AIVL consultations and projects last year. The resources are education campaign-style materials, providing basic information and are pitched at an awareness raising and conversation starter level, rather than being long and detailed. As such, the resources are also more readily accessible for low-literacy and culturally diverse audiences.
Hepatitis C & Prison
Methamphetamine Use & Blood Borne Virus/Sexually Transmissible Infection (BBV/STI)
Lyrica (pregabalin) and Mental Health
New buprenorphine (Bupe) depot products
Hard copies of these new resources have now been printed and can be ordered by contacting Harini Walthati via email on hariniw@aivl.org.au.
AIVL have also updated some of their popular resources, which can also be found on the website:
The Vein Care Guide
Liver First
Coming soon: Changes to PrEP Prescribing
ASHM have reported that their submission to the Pharmaceutical Benefits Advisory Committee to change the PBS criteria for prescribing PrEP has been successful. Soon it will be easier than ever to prescribe PBS-funded PrEP, making PrEP more accessible.
Key changes include the removal of restrictive high and medium HIV risk, and aligning it with the PrEP suitability criteria in the 2019 updated ASHM PrEP guidelines. In addition, the restriction level has been reduced from “Authority Required” to a “Restricted Benefit” to support broad access for patients who are at risk of HIV infection.
Watch this space for further information about the changes, when they’ll come into effect and how this will impact our sector.
New report: Women in contact with the Sydney LGBTIQ communities: Report of the SWASH Lesbian, Bisexual and Queer Women’s Health Survey 2016, 2018, 2020.
A lack of systematic, nuanced research on the health and wellbeing of Australian lesbian, bisexual and queer (LBQ) women (cis and trans) has been a significant barrier to understanding, recognising and addressing their health needs. The SWASH survey is a comprehensive survey of important health issues relevant to lesbian, bisexual, queer and other non-heterosexual identifying women engaged with Sydney’s lesbian, gay, bisexual, transgender, intersex and queer (LGBTIQ) communities. These data provide unparalleled insights into the health of lesbian, bisexual, queer and other non-heterosexual identifying women aged 16 to 71 years who engaged with LGBTIQ communities in and around Sydney (where 85% of respondents reside). Download the SWASH report .
HIV Policy Lab
New in 2020, the HIV Policy Lab website offers summaries and visualizations across 33 different policies, as well as a growing reference library of policy documents. Users are invited to help update the database by sharing law and policy information with our team of analysts to help keep the site up to date. The policy map contains global HIV Incidence and ART Treatment Data, searchable by country and region. You can read more about the HIV Policy Lab here .
Latest reports from the Illicit Drug Reporting System 2020
Speakeasy is back, two new episodes
S05, Ep5: Doom scrolling, murder mysteries and silver linings
Of Pride, Othering and Other Things…
Other shiny picks from the www
Renewed Calls for Needle & Syringe Programs in Prisons Ahead of International Drug Users Day
Nurse Practitioner earns right to prescribe HIV medicines
The man who died before his disease had a name
PrEP does not protect against COVID-19 or make the disease less severe
What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?
Past webinars
Hepatitis C treatment-as-prevention in Australian prisons: the SToP-C study
Treatment-as-prevention incorporates treatment as a tool for limiting spread of an infection in epidemics in a particular setting. The Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) study is the first study globally, providing empirical data of hepatitis C treatment-as-prevention in the prison setting. Watch the SToP-C webinar .
Upcoming events
Report Launch: Private Lives 3
Friday 13 November, 2pm–3:30pm
The Australian Research Centre in Sex, Health and Society (ARCSHS) at La Trobe University is excited to launch the latest iteration of their flagship Private Lives research series, Private Lives 3.
Private Lives is a large national survey of the health and wellbeing of LGBTIQ people in Australia, and at the time of its inception in 2006, was one of the largest surveys of its kind anywhere in the world. The last Private Lives survey appeared in 2012, and this new survey provides an up-to-date picture of the health and wellbeing of LGBTIQ people living in Australia today.
The launch will be conducted over Zoom webinar, and will feature Victorian Minister for Health and Minister for Equality The Hon. Martin Foley, a range of other speakers as well as a discussion panel of community leaders. RSVP for the launch .
EC Australia Webinar Series: EC Australia Aboriginal health strategy
Wednesday 18 November, 12pm-1:30pm
This session will present latest hepatitis C data from a national sentinel surveillance network of Aboriginal Community Controlled Health Organisations (ATLAS network) and the results of The Goanna Survey 2; a study of knowledge, risk practices and health service access for sexually transmissible infections (STIs) and blood-borne viruses (BBVs) among young Aboriginal and Torres Strait Islander people.
The webinar will also showcase micro-elimination approaches from two local Aboriginal Community Controlled Health Organisations based on outer regional and urban settings and one peer-based model for service delivery.
· Chair: Mr Troy Combo and Dr Alisa Pedrana
· Presenters: - Professor James Ward (UQ) - Associate Professor Linda Selvey (UQ) - Dr Richard Mills & Renee Brown (IUIH) - Dr Sue Amaresena (Walhallow Aboriginal Health Service) - Wahida Ul Haq & Dr Lakhbinder Kang (Derbal Yerrigan Health Service) - Colin Mickelo (QuIHN)
All details here .
International students and sexual health – where is the evidence?
Wednesday 25 November, 10am-11am
Join us for this free webinar hosted by the Community of Practice for Action on HIV and Mobility. Findings and learnings from recent Australian work with international students and sexual health will be discussed, with a focus on where to next.
Hear from the following guest presenters:
· Hiromi Takahashi is completing a Master of Sexology at Curtin University, and is undertaking practicum work at the Sexual Health and Blood-borne Virus Applied Research and Evaluation Network. She is involved with CoPAHM WA .
· Dr Judith Dean is a Senior Research Fellow within the STI, HIV, and other BBV Research Hub at The University of Queensland, Australia. She is a Registered Nurse/Midwife and is a member of CoPAHM QLD.
· A/Prof Limin Mao is an Associate Professor at the Centre for Social Research in Health, University of New South Wales. Her research has had a strong focus on risk perceptions; prevention of blood-borne viruses including HIV, Hepatitis and other sexually transmissible infections, health promotion, monitoring and evaluation; infectious diseases prevention, treatment and care and mHealth.
· Carolyn Slattery is a Sexual Health Senior Program Manager with the STI Programs Unit, NSW Ministry of Health.
The event will be facilitated by Alison Coelho, Co-Manager at CEH, who oversees the Multicultural Health & Support Service (MHSS). Alison chairs the International Student Sexual Health Network.
Registration and information here .
EC Australia Webinar series: Australia’s Progress towards Hepatitis C Elimination 2020
Wednesday 25 November, 12pm-1:30pm
The final webinar in the EC series will launch the second annual ‘Australia’s progress towards hepatitis C elimination’ report, jointly published by the Burnet and Kirby Institutes.
The report brings together data from over 20 sources and provides an overview of progress towards hepatitis C elimination in key areas including; trends in new infections, testing and diagnosis, treatment uptake and outcomes, morbidity, stigma and discrimination, primary prevention, equity, and mathematical modelling.
The 2020 report has updated data and new data sources, but also highlights some ongoing gaps in our understanding of progress towards elimination.
Highlights of the report will be presented alongside an opportunity to ask questions and discuss the dissemination of the report in the sector and beyond to optimise its utility.
· Chair: Dr Anna Wilkinson Presenters:
· Professor Margaret Hellard AM and Professor Gregory Dore
Register here .
World AIDS Day: Tuesday 1 December
All are invited to participate in WAD online events to acknowledge that people living with HIV are not forgotten, and that we continue in our efforts toward the prevention of HIV, the removal of barriers to testing & treatment and access to services without judgement and stigma.
9am-10am
The official World AIDS Day Launch will feature presentations from:
- The Hon. Martin Foley, Victorian Minister for Health
- Chad Hughes, Deputy Program Director of Disease Elimination at the Burnet Institute
- Bruce Sanchez from Living Positive Victoria’s Positive Speakers Bureau
- Bev Trotter from Living Positive Victoria’s Positive Speakers Bureau
- Christabel Millar, President of Living Positive Victoria.
This event will be presented via Zoom. Access details will be emailed to all registrants 24 hours prior to the event. Register here .
11am-12pm
The World AIDS Day Community Forum will be hosted by the Burnet Institute. The theme for the panel discussion is “HIV and COVID: lessons learned and issues raised“.
Moderated by Dr Chris Lemoh from Monash Health
Speakers:
- Carol El Hayek from the Burnet Institute
- Vicky Saputra from Living Positive Victoria’s Positive Speakers Bureau
- Hope Mathumbu from VAHAN
- Dr Tafi Marukutira from the Burnet Institute
- Valentina Gamarra from Living Positive Victoria’s Positive Speakers Bureau
This event will be presented via Zoom. Access details will be emailed to all registrants 24 hours prior to the event. Register here .
1pm-5pm
The mHIVE World AIDS Day Symposium will be hosted by the mHIVE Consortium.
The Living with HIV Perspective will run from 2:40-3:20pm. This year’s community forum will have the theme “Living with HIV in a COVID-19 world“. We are hoping to discuss how PLWH have been affected by COVID-19, the lessons we can learn from both pandemics and stigma associated with both HIV and COVID-19.
Moderated by Assoc Prof Graham Brown (Centre for Social Impact, UNSW)
Speakers:
- Richard Keane from Living Positive Victoria
- Heather Ellis from Positive Women Victoria
- Dean Beck, ENUF Ambassador
This event will be presented via Zoom. Access details will be emailed to all registrants 24 hours prior to the event. Register here .
CSRH Seminar: How can we strengthen the role of families in the response to blood borne viruses?
Wednesday 2 December, 3pm-4pm
The clinical management of blood borne viruses has changed rapidly in recent years, but social stigma remains a persistent issue. Anecdotally, we know that families living with serodiscordance (i.e. mixed infection status) play a critical role in supporting those who have been diagnosed with HIV, hepatitis B and/or hepatitis C. And yet both research and policy responses have remained largely focused on the affected individual.
This seminar will discuss key findings from the first qualitative interview study to explore how Australian families respond to and are affected by blood borne viruses. Although the concept of ‘family’, much like those of ‘care’ and ‘risk’, is neither simple nor static, project findings suggest there could be many benefits in more deliberately recognising and supporting the role of families in remediating the health and social impacts of these infections.
- Associate Professor Christy Newman conducts social research on health, gender and sexuality, with a focus on communities affected by stigma, prejudice and marginalisation.
- Dr Asha Persson is a Senior Research Fellow at CSRH, where she has conducted a range of qualitative projects on various cultural and lived aspects of HIV, with a particular focus on under-researched populations.
- Dr Kerryn Drysdale is a Research Fellow at CSRH. Her current area of research lies at the intersection of social inquiry and public health for marginalised populations.
- Anthony K J Smith is a Scientia PhD Candidate and research assistant at CSRH. He researches social aspects of health, HIV, PrEP, gender, and sexuality.
Register here.
12th Australasian Viral Hepatitis Conference: 30 May to 1 June 2021
Dates have been set for VH21 which will be held in Brisbane. Abstracts submissions can now be made on the theme ‘Progress towards hepatitis elimination targets: Taking stock and innovating for the future’. The 12th Australasian Viral Hepatitis Conference is an excellent opportunity to showcase new research, increase knowledge, and collaborate with the sector.
The Australasian Viral Hepatitis Conference is run by ASHM in collaboration with key sector partners as a platform for the dissemination and presentation of new and innovative research findings and better management across the Australasian viral hepatitis sector.
The case for simplifying and using absolute targets for viral hepatitis elimination goals
Talking testing: Impact of a training intervention on midwives’ antenatal HIV, hepatitis B and hepatitis C screening practice
Time for revolution? Enhancing meaningful involvement of people living with HIV and affected communities in HIV cure-focused science
Long-acting injectables appear feasible for long-term HIV treatment
The role of mobility in sexual risk behaviour and HIV acquisition among sub-Saharan African migrants residing in two European cities
HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016–2018
Impact of the COVID-19 Pandemic on the Medical Follow-up and Psychosocial Well-Being of People Living With HIV: A Cross-Sectional Survey
Burden of living with HIV among men who have sex with men: a mixed-methods study
COVID-19 Susceptibility and Outcomes among People Living with HIV in San Francisco
Crystal Methamphetamine Use and Initiation among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV in a Treatment as Prevention Environment
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach
Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis
Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework
‘It's like getting an Uber for sex’: social networking apps as spaces of risk and opportunity in the Philippines among men who have sex with men
Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States—National HIV Behavioral Surveillance, 5 US Cities, 2017
Weight gain on HIV treatment: what is normal, and what is harmful?
Long-acting injectables work without oral lead-in period
Two-thirds of people living with HIV would like to try injectable treatment, according to European survey
Biological, clinical and ethical imperatives for involving diverse women in HIV clinical trials
Meta-synthesis of Qualitative Research of Pre-exposure Prophylaxis (PrEP) Adherence Among Men Who Have Sex With Men (MSM)
Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May–July 2019, UK
On-demand HIV pre-exposure prophylaxis: what are the healthcare workers’ barriers to delivery in a culturally and linguistically diverse population?
Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition
Chronic hepatitis B in children, report of a single‐centre longitudinal study on 152 children
A multi‐centre study of trends in hepatitis B virus‐related hepatocellular carcinoma risk over time during long‐term entecavir therapy
Clinical characteristics in patients with SARS‐CoV‐2/HBV co‐infection
A predictive model for hepatitis B infection among high‐risk adults using a community‐based sample in greater Philadelphia
HBV RNA profiles in chronic hepatitis B patients under different disease phases and anti‐viral therapy
Peer to peer communication about hepatitis C treatment amongst people who inject drugs: A longitudinal qualitative study
Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics
Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial
Creating an environment for equitable access to direct‐acting antiviral therapy for people who inject drugs with hepatitis C
Outcomes of community‐based hepatitis C treatment by general practitioners and nurses in Australia via remote specialist consultation
Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)
Association of Hepatitis C Infection and Risk of Kidney Cancer: A Systematic Review and Meta‐analysis of Observational Studies
Hepatitis C Testing and Treatment Uptake among Young People who Use Opioids in New York City: A Cross‐Sectional Study
Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service
B protected: from vertical HCV transmission?
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study
Fatty liver disease common in people living with HIV and hepatitis B
Exclusion and hospitality: the subtle dynamics of stigma in healthcare access for people emerging from alcohol and other drug treatment
Assisted injection within supervised injection services: Uptake and client characteristics among people who require help injecting in a Canadian setting
Injecting drug use, the skin and vasculature
Factors associated with sexually transmitted infection diagnosis in women who have sex with women, women who have sex with men and women who have sex with both
Use of doxycycline and other antibiotics to prevent STIs among men who have sex with men visiting sexual health clinics in the Netherlands
Forward to a Friend
|